---
title: "GLOBAL BIO-CHEM announces interim results, with a net loss attributable to owners of approximately HKD 158 million, a year-on-year increase of 1.43 times"
description: "GLOBAL BIO-CHEM announced its mid-term performance for 2024, with revenue of approximately HKD 898.5 million, a year-on-year increase of 91.7%. However, the company's owners' share of losses amounted "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/212046258.md"
published_at: "2024-08-20T12:42:04.000Z"
---

# GLOBAL BIO-CHEM announces interim results, with a net loss attributable to owners of approximately HKD 158 million, a year-on-year increase of 1.43 times

> GLOBAL BIO-CHEM announced its mid-term performance for 2024, with revenue of approximately HKD 898.5 million, a year-on-year increase of 91.7%. However, the company's owners' share of losses amounted to approximately HKD 158 million, a 1.43-fold increase year-on-year, resulting in a loss per share of 1.8 HK cents. The revenue growth mainly stemmed from the increase in production capacity of the amino acid business and the launch of high value-added products, while the expanded losses were due to the absence of income from the termination of the recognition of Harbin Global Bio-Chem during the same period

According to the news from Wisdom Finance APP, Global Bio-Chem Technology (00809) announced its mid-term performance for 2024, with a revenue of approximately HKD 898.5 million from continuing operations, an increase of about 91.7% year-on-year; the attributable loss to owners of the company was approximately HKD 158 million, an increase of 1.43 times year-on-year; with a loss per share of 1.8 HK cents.

The announcement stated that the revenue growth was due to the group's efforts to maximize the production capacity of its amino acid business facilities and introduce a series of high value-added amino acid products to expand sales in the first half of 2024. The expanded loss was due to the absence of one-time income from the termination of the recognition of Harbin Global Bio-Chem during the period (approximately HKD 588.7 million in the same period last year)

### Related Stocks

- [00809.HK - GLOBAL BIO-CHEM](https://longbridge.com/en/quote/00809.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges | NVIDIA's Q4 2025 13F filing reveals significant shifts in its public equity portfolio, adding Intel, Synopsys, and Nokia | [Link](https://longbridge.com/en/news/276480737.md) |
| Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | [Link](https://longbridge.com/en/news/276265837.md) |
| Hassett says New York Fed staff should be disciplined over study finding Americans paid for Trump's tariffs | Kevin Hassett, a White House economist, criticized a Federal Reserve Bank of New York study claiming that nearly 90% of  | [Link](https://longbridge.com/en/news/276253470.md) |
| Berkshire Hathaway discloses investment in New York Times | Berkshire Hathaway has disclosed a new investment in the New York Times, reentering a sector it left in 2020. The compan | [Link](https://longbridge.com/en/news/276173033.md) |
| Deep-sea fish break the mold with novel visual system | New research has identified a novel type of visual cell in deep-sea fish, blending features of rods and cones, adapted f | [Link](https://longbridge.com/en/news/276218702.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.